Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-3172.53%
operating margin TTM
-3318.21%
revenue TTM
16.73 Million
revenue per share TTM
9.56$
valuation ratios | |
|---|---|
| pe ratio | -6.94 |
| peg ratio | -0.66 |
| price to book ratio | 1.74 |
| price to sales ratio | 20.33 |
| enterprise value multiple | 1.45 |
| price fair value | 1.74 |
profitability ratios | |
|---|---|
| gross profit margin | 89.75% |
| operating profit margin | -3318.21% |
| pretax profit margin | 1171.35% |
| net profit margin | -3172.53% |
| return on assets | -19.77% |
| return on equity | -25.85% |
| return on capital employed | -22.24% |
liquidity ratios | |
|---|---|
| current ratio | 0.19 |
| quick ratio | 0.16 |
| cash ratio | 0.05 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 1,278.21 |
| operating cycle | 1,642.74 |
| days of payables outstanding | 20,018.13 |
| cash conversion cycle | -18,375.39 |
| receivables turnover | 1.00 |
| payables turnover | 0.02 |
| inventory turnover | 0.29 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | -14.74 |
| cash flow to debt ratio | -5.01 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.53 |
| cash per share | 0.02 |
| operating cash flow per share | -0.53 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -5.01 |
| short term coverage ratios | -5.01 |
| capital expenditure coverage ratio | -3,379,175.00 |
Frequently Asked Questions
When was the last time TRxADE HEALTH, Inc. (NASDAQ:MEDS) reported earnings?
TRxADE HEALTH, Inc. (MEDS) published its most recent earnings results on 12-11-2025.
What is TRxADE HEALTH, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. TRxADE HEALTH, Inc. (NASDAQ:MEDS)'s trailing twelve months ROE is -25.85%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. TRxADE HEALTH, Inc. (MEDS) currently has a ROA of -19.77%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MEDS's net profit margin stand at?
MEDS reported a profit margin of -3172.53% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MEDS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.19 in the most recent quarter. The quick ratio stood at 0.16, with a Debt/Eq ratio of 0.02.